Abstract
Purpose
IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis worldwide. However, the effect of the degree of tubulointerstitial lesions (TIL) on the renal prognosis of these patients is uncertain.
Methods
All biopsy-proven primary IgAN patients from a single center (≥ 14 years old) were retrospectively examined from January 2006 to December 2011. According to the Oxford classification for tubulointerstitial lesions in IgAN, eligible patients were assigned to T0 or T1/2 groups. The clinicopathological features of these groups were compared and multivariate models were used to identify the effect of tubulointerstitial lesions on renal prognosis. The composite endpoint was end-stage renal disease or doubling of serum creatinine.
Results
We initially identified 1570 patients with IgAN and examined 988 patients who completed follow-up examinations (mean: 49 months). There were 506 patients in the T0 group (51.2%) and 482 in the T1/2 group (48.8%). The 1-year, 3-year, and 5-year incidences of the composite endpoint were 0.2%, 1.5%, 7.7% in the T0 group, and 1.9%, 9.9%, 18.1% in the T1/2 group. An adjusted multivariate model indicated the hazard ratio for reaching the composite endpoint was 9.3 for patients with T1/2 rather than T0 (reference group). A multivariate logistic analysis of the T1/2 group indicated the independent risk factors for reaching the composite endpoint were decreased eGFR, hypertension, hyperlipidemia, proteinuria, global glomerulosclerosis, and segmental glomerulosclerosis.
Conclusion
More severe tubulointerstitial lesions (> 25%, T1/2) were an independent predictor of poor renal prognosis in patients with IgAN.
Similar content being viewed by others
Availability of data and material
The datasets generated and analyzed in the present study are available from the corresponding author upon reasonable request.
References
Xie J, Chen N (2013) Primary glomerulonephritis in mainland China: an overview. Contrib Nephrol 181:1–11
Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738–748
Barratt J, Feehally J (2005) IgA nephropathy. J Am Soc Nephrol 16:2088–2097
Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545
Zeng CH, Le W, Ni Z et al (2012) A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis 60:812–820
Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C (2011) The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol 6:2384–2388
Ma YC, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944
Lai KN, Chan LY, Leung JC (2005) Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int Suppl 67:S110–S115
Alexander S, Varughese S, Franklin R et al (2021) Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort. Kidney Int Rep 6:414–428
Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ (2011) The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol 34:435–444
Haruhara K, Tsuboi N, Koike K, Kanzaki G, Okabayashi Y, Miyazaki Y, Kawamura T, Ogura M, Yokoo T (2015) Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy. Clin Kidney J 8:716–721
Kamiyama T, Moriyama T, Kumon S, Karasawa K, Nitta K (2019) The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification. Clin Exp Nephrol 23:834–840
Moriyama T, Karasawa K, Miyabe Y et al (2020) Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors. Sci Rep 10:11151
Maixnerova D, Bauerova L, Skibova J, Rysava R, Reiterova J, Merta M, Honsova E, Tesar V (2012) The retrospective analysis of 343 Czech patients with IgA nephropathy–one centre experience. Nephrol Dial Transplant 27:1492–1498
Barbour S, Reich H (2018) An update on predicting renal progression in IgA nephropathy. Curr Opin Nephrol Hypertens 27:214–220
Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, Xu F, Liang D, Zeng C, Liu Z (2019) Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis 74:300–309
Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z (2012) Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27:1479–1485
Wang J, He L, Yan W, Peng X, He L, Yang D, Liu H, Peng Y (2020) The role of hypertriglyceridemia and treatment patterns in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis. Int Urol Nephrol 52:325–335
Acknowledgements
None.
Funding
This work was supported by grants from the Chinese National Key Technology R and D Program, Ministry of Science and Technology (No. 2017YFC0907601, No. 2017YFC0907602, and No. 2017YFC0907603, No. 2016YFC0906100, No. 2016YFC0906101); National Natural Science Foundation of China (No. 81970599 and No. 82170737); Natural Science Foundation of Guangdong Province (No. 2018A030313880); Guangzhou Municipal Program of Science and Technology (No. 201804020049); Key Laboratory of National Health Commission, and Key Laboratory of Nephrology, Guangdong Province, Guangzhou, China (No. 2002B60118 and 2017B030314019, 2020B1212060028).
Author information
Authors and Affiliations
Contributions
TXQ, YQQ and CW conceived and designed research; TXQ and WQ collected data and conducted research; TXQ, WQ and ZQ analyzed and interpreted data; TXQ and WQ wrote the initial paper; CW and YXQ revised the paper; CW had primary responsibility for final content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors have no financial interests or any conflicts of interest to disclose.
Ethics approval
This study was approved by the Ethics Committee of The First Affiliated Hospital, Sun Yat-sen University (Guangzhou, China). All procedures performed in studies involving human participants were in accordance with the ethics standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethics standards.
Consent to participate
Written informed consent was obtained from all individual participant or legal guardian included in the study.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tang, X., Wen, Q., Zhou, Q. et al. Prognostic significance of the extent of tubulointerstitial lesions in patients with IgA nephropathy. Int Urol Nephrol 55, 671–677 (2023). https://doi.org/10.1007/s11255-022-03286-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03286-2